These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35932380)

  • 1. Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors.
    Bergholtz H; Lien T; Lingaas F; Sørlie T
    J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):171-183. PubMed ID: 35932380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.
    Watson J; Wang T; Ho KL; Feng Y; Mahawan T; Dobbin KK; Zhao S
    Breast Cancer Res; 2023 Oct; 25(1):114. PubMed ID: 37789381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-species oncogenic signatures of breast cancer in canine mammary tumors.
    Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S
    Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.
    Watson J; Wang T; Ho KL; Feng Y; Dobbin KK; Zhao S
    bioRxiv; 2023 Mar; ():. PubMed ID: 37034591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.
    Sweeney C; Bernard PS; Factor RE; Kwan ML; Habel LA; Quesenberry CP; Shakespear K; Weltzien EK; Stijleman IJ; Davis CA; Ebbert MT; Castillo A; Kushi LH; Caan BJ
    Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):714-24. PubMed ID: 24521995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer.
    Liu D; Xiong H; Ellis AE; Northrup NC; Rodriguez CO; O'Regan RM; Dalton S; Zhao S
    Cancer Res; 2014 Sep; 74(18):5045-56. PubMed ID: 25082814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Molecular Subtypes of Rat Mammary Cancer and Their Association With Environmental Exposures.
    Nishimura Y; Iizuka D; Takabatake M; Daino K; Nishimura M; Morioka T; Shimada Y; Kakinuma S; Imaoka T
    Anticancer Res; 2024 Oct; 44(10):4261-4272. PubMed ID: 39348980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
    Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
    Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis.
    Seung BJ; Cho SH; Kim SH; Lim HY; Sur JH
    PLoS One; 2020; 15(2):e0229031. PubMed ID: 32059046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
    Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
    Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
    Herschkowitz JI; Zhao W; Zhang M; Usary J; Murrow G; Edwards D; Knezevic J; Greene SB; Darr D; Troester MA; Hilsenbeck SG; Medina D; Perou CM; Rosen JM
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2778-83. PubMed ID: 21633010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
    Klopfleisch R; Lenze D; Hummel M; Gruber AD
    BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
    Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
    PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
    Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
    Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
    Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
    Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
    Prat A; Carey LA; Adamo B; Vidal M; Tabernero J; Cortés J; Parker JS; Perou CM; Baselga J
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25139534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
    Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
    Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.